CLVLFClinuvel Pharmaceuticals Ltd.

About Clinuvel Pharmaceuticals Ltd. (CLVLF)

Clinuvel Pharmaceuticals Ltd. (CLVLF) is a Biotechnology company headquartered in Melbourne, VA, Australia whose shares trade over-the-counter on the Pink tier.

Clinuvel Pharmaceuticals Ltd is a global biopharmaceutical company focused on developing drugs for the treatment of a range of severe skin disorders. With our unique expertise in understanding the interaction of light and human skin, we have identified three groups of patients with a clinical need for photoprotection and another group with a need for repigmentation. These patient groups range in size from 10,000 to 45 million.

CLVLF key facts

Ticker symbol

CLVLF

Market tier

Pink

Sector

Healthcare

Industry

Biotechnology

Headquarters

Melbourne, VA, Australia

Country of incorporation

AU

Estimated market cap

$343.40M (as of May 9, 2025)

Shares outstanding

49,410,338

Reporting standard

International Reporting: ASX - Australian Securities Exchange

Audit status

Audited

Fiscal year end

6/30

Clinuvel Pharmaceuticals Ltd. leadership

• Philippe Wolgen — CEO
• Darren Keamy — CFO
• Colin Mackie — Director, Bus. Dev.

Explore more: Biotechnology stocks · Healthcare sector · Pink stocks · OTC stocks starting with C